Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery



Status:Recruiting
Conditions:Other Indications, Overactive Bladder, Women's Studies, Urology, Urology, Urology
Therapuetic Areas:Gastroenterology, Nephrology / Urology, Other, Reproductive
Healthy:No
Age Range:18 - Any
Updated:10/13/2018
Start Date:August 1, 2018
End Date:December 31, 2019
Contact:Graham Chapman, MD
Email:graham.chapman@uhhospitals.org
Phone:4409155543

Use our guide to learn which trials are right for you!

Perioperative Administration of Tamsulosin vs Placebo to Prevent Postoperative Urinary Retention in Female Pelvic Reconstructive Surgery

This is a placebo controlled randomized controlled trial of perioperative use of tamsulosin
to prevent postoperative urinary retention in female pelvic reconstructive surgery.


Inclusion Criteria:

- Patients must be 18 years or older as well as willing and able to provide informed
consent

- Patients must be undergoing a scheduled surgery for pelvic organ prolapse or urinary
incontinence

- Standard postoperative plan must include admission to the hospital with foley
catheterization overnight the night after surgery, and planned removal of foley
catheter and active voiding trial on postoperative day 1.

Exclusion Criteria:

- Patient unable or unwilling to provide informed consent

- Severe allergy to sulfa drugs

- Known allergy to tamsulosin or another alpha antagonist medication

- History of urinary retention

- Planned bladder catheterization greater than 24 hours after surgery

- Current use of alpha antagonist medication for hypertension

- End stage renal or liver disease
We found this trial at
2
sites
Cleveland, Ohio 44012
Phone: 440-915-5543
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cleveland, Ohio 44106
Phone: 440-915-5543
?
mi
from
Cleveland, OH
Click here to add this to my saved trials